SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-117219
Filing Date
2023-11-13
Accepted
2023-11-13 16:13:28
Documents
14
Period of Report
2023-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2330300d1_8k.htm   iXBRL 8-K 27290
2 EXHIBIT 99.1 tm2330300d1_ex99-1.htm EX-99.1 39458
6 GRAPHIC tm2330300d1_img001.jpg GRAPHIC 15898
  Complete submission text file 0001104659-23-117219.txt   268591

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rzlt-20231113.xsd EX-101.SCH 3024
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rzlt-20231113_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rzlt-20231113_pre.xml EX-101.PRE 22365
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2330300d1_8k_htm.xml XML 3311
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39683 | Film No.: 231398869
SIC: 2834 Pharmaceutical Preparations